Dimopoulos, M A
Roussou, M
Gavriatopoulou, M
Fotiou, D
Ziogas, D C
Migkou, M
Panagiotidis, I
Eleutherakis-Papaiakovou, E
Kanellias, N
Psimenou, E
Marinaki, S
Bacharaki, D
Mparmparoussi, D
Matsouka, C
Giannouli, S
Terpos, E
Kastritis, E
Article History
First Online: 16 June 2017
Competing interests
: EK: Genesis Pharma, Takeda, Janssen Amgen, Prothena; ET: BMS, Janssen, Celgene, Takeda Genesis Pharma, Amgen, Novartis and MAD: Novartis, Janssen, Celgene, Takeda, BMS, Amgen. The remaining authors declare no conflict of interest.